Clinical Trial Update: Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from GlaxoSmithKline on preventing chemotherapy-induced nausea and vomiting caused by moderately emetogenic chemotherapy; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced, Chemotherapy-Induced Nausea and Vomiting | Phase 2 | Status: COMPLETED